To include your compound in the COVID-19 Resource Center, submit it here.

Amylin, Eli Lilly sales and marketing update

Amylin reported in its 2Q11 earnings that partner Eli Lilly launched once-weekly Bydureon exenatide in the

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE